NGENLA
NGENLA
Approved
DIN Number
02521687
Drug Class
Human
Market Date
Feb 22, 2022
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02521687
AIG Number0163234002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
H01AC08 SOMATROGON
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SOMATROGONActive
Strength: 50 MG / ML
Monograph: SOMATROGON